admin Nestlé has introduced protein shots in the United States, claiming they help curb appetite for those aiming to lose weight. This marks the latest move by the world’s largest packaged food company to enter the rapidly growing weight-loss market.
The maker of Kit Kat chocolate bars and Nesquik drinks says its new product triggers a natural response in the body similar to, but far less potent than, popular weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. These drugs mimic the intestinal hormone GLP-1, reducing appetite and increasing feelings of fullness.
Nestlé’s shake, called Boost Pre-Meal Hunger Support, is designed for use 30 minutes before meals and is particularly targeted at those already using GLP-1 drugs or other weight-loss medications. The product, launched last month, aims to complement such treatments.
“You experience a natural increase in GLP-1, which helps control hunger and enhances satiety,” said Stefan Palzer, Nestlé’s Chief Technology Officer.
Sold for $10.99 for a pack of four on Amazon.com and in select CVS stores, the shots provide 10 grams of whey protein, 45 calories, one gram of sugar, and are fat-free. They are marketed as encouraging a “natural GLP-1 response to meals.”
According to Palzer, the shots may also help people maintain their weight loss over time.
However, Lora Heisler, chair of human nutrition and research director at the Rowett Institute, expressed caution. “While this protein shot may stimulate GLP-1 release, similar effects might be achieved with a glass of milk,” she noted.
Earlier this year, Nestlé launched a $5 line of frozen pizzas and protein-enriched pasta in the US, catering to those taking weight-loss medications.
Analysts predict the global obesity drug market could grow to $150 billion annually within a decade. Last year, Walmart reported a slight decline in food consumption among users of such medications, prompting a sell-off in shares of companies like Nestlé.
Magazine 
